The Promise of Dolutegravir: A Novel Second Generation Integrase Strand Transfer Inhibitor

E-ISSN： 2212-3938|11|2|88-94

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.11, Iss.2, 2016-08, pp. : 88-94

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Second Generation HIV Integrase Inhibitor-DOLUTEGRAVIR: An Emerging Weapon Against HIV

Letters in Drug Design & Discovery, Vol. 14, Iss. 3, 2017-01 ,pp. : 354-371

Bentham Science Publishers

Access to resources Recommend Favorite

Drug safety profile of integrase strand transfer inhibitors

By del Mar Gutierrez Maria Mateo Maria Gracia Vidal Francesc Domingo Pere

Expert Opinion on Drug Safety, Vol. 13, Iss. 4, 2014-04 ,pp. : 431-445

Informa Healthcare

Access to resources Recommend Favorite

Design of Second Generation HIV-1 Integrase Inhibitors

Current Pharmaceutical Design, Vol. 13, Iss. 2, 2007-01 ,pp. : 129-141

Bentham Science Publishers

Access to resources Recommend Favorite

New first and second generation inhibitors of human immunodeficiency virus-1 integrase

By Pendri Annapurna Meanwell Nicholas A Peese Kevin M Walker Michael A

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 8, 2011-08 ,pp. : 1173-1189

Informa Healthcare

Access to resources Recommend Favorite

Novel integrase inhibitor promising in triple-class resistant HIV-1

Inpharma, Vol. 1, Iss. 1560, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite